Renub Research has recently published a report titled ” Embolic Protection Device Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis,” providing a comprehensive analysis of the industry that includes market share insights. In addition, the report comprises competitor and regional research and contemporary extension. Embolic Protection Devices Market studied was projected to grow with a CAGR of 7.90% over the forecast period (2022-2027). Embolic protection devices (EPDs) were originally designed to provide cerebral protection during carotid artery stenting, leading to notable reductions in stroke and mortality rates.
The market for EPDs is experiencing significant growth driven by several key factors. Firstly, there is a rising prevalence of cardiovascular, peripheral, and neurovascular surgeries, creating a greater demand for these devices. Moreover, substantial investments in research and development efforts focused on improving embolic devices have further propelled market expansion. Additionally, the increasing number of Trans-catheter Aortic Valve Replacement (TAVR) procedures and the growing awareness among consumers about the advantages of embolic devices are also contributing to the overall development of the Embolic Prevention Devices Market. Embolic Protection Device Market is projected to reach a value of US$ 713.6 Million by 2027 due to the sharp increase in the number of people suffering from various cardiovascular and neurovascular illnesses
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=embolic-protection-device-market-p.php
The World Heart Federation (WHF) reports that stroke affects approximately 15 million individuals annually. The increasing prevalence of cardiovascular disorders worldwide, attributed to the growing geriatric population, is a key factor driving the market growth. The World Health Organization (WHO) projects that the global population aged 60 and above will reach 1.6 billion by 2050, further supporting this trend.
|Historical Period||2018 – 2022|
|Forecast Period||2023 – 2027|
|Segment Covered||Product, Application, End User, and Region|
|Regions Covered||North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa|
|Companies Covered||Medtronic, Abbott Laboratories, Boston Scientific, Cordis, Silk Road Medical, Abiomed, and Edwards Lifesciences Corporation|
|Customization Scope||20% Free Customization|
|Post-Sale Analyst Support||1 Year (52 Weeks)|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)|
Government bodies, along with Non-Governmental Organizations (NGOs) and educational institutes, are actively involved in raising awareness about cardiovascular and neurovascular diseases, as well as their potential treatments, through awareness programs. This proactive approach contributes to the expansion of the market. However, the presence of alternative treatments such as drug therapies and the high cost of medical devices may pose challenges to market growth.
Distar Filter segment has witnessed a rapid expansion in theEmbolic Protection Devices Market
The Distar Filter market is anticipated to experience strong demand in the worldwide embolic protection devices market in the upcoming years. With the increasing prevalence of cardiovascular diseases and the rising number of interventional procedures, the need for effective embolic protection is growing. Distar Filters, known for their efficiency in capturing debris and preventing embolization, are expected to witness significant demand. Additionally, the expanding geriatric population and initiatives to raise awareness about the benefits of embolic protection devices further contribute to the market demand for Distar Filters in the global embolic protection devices market.
Product – Embolic Protection Devices Market breakup from 3 viewpoints:
- Distal Filter Devices
- Distal Occlusion Devices
- Proximal Occlusion Devices
The increasing prevalence of peripheral vascular diseases is expected to foster positive growth in theEmbolic Protection Devices Market
The prevalence of peripheral vascular diseases, such as Peripheral Artery Disease (PAD), presents considerable health risks and necessitates effective treatment strategies. As awareness surrounding these conditions continues to grow and the demand for minimally invasive procedures rises, the importance of embolic protection devices becomes paramount. Embolic protection devices offer crucial protection against the release of emboli during interventional procedures, significantly reducing the risk of complications. With ongoing technological advancements and a heightened focus on patient safety, Embolic Protection Devices Market is expected to witness favourable growth in direct response to the increasing prevalence of peripheral vascular diseases.
Application – Embolic Protection Devices Market breakup from 3 viewpoints:
- Cardiovascular diseases
- Neurovascular diseases
- Peripheral vascular diseases
Hospital dominance is driven by rising cardiovascular diseases, skilled medical personnel, increasing surgical procedures, and advanced medical devices
The hospitals segment is expected to witness significant growth in the Embolic Protection Devices Market in the coming years. Hospitals hold a pivotal role in the diagnosis and treatment of various medical conditions, particularly cardiovascular diseases and neurovascular disorders that necessitate the use of embolic protection devices. Factors such as the escalating prevalence of these diseases, advancements in medical technology, and the availability of skilled healthcare professionals contribute to the expansion of the hospitals segment. Additionally, hospitals offer comprehensive care services, including surgical interventions, making them a vital setting for the adoption of embolic protection devices. These factors collectively drive the projected substantial growth of the hospitals segment in the Embolic Protection Devices Market.
End-user – Embolic Protection Devices Market breakup from 2 viewpoints:
- Ambulatory Surgical Centres
North America is projected to maintain its dominant position in the overall Embolic Prevention Devices Market throughout the forecast period
North America continues to dominate the market and is expected to maintain its leading position in the forecast period. The region’s dominance can be attributed to various factors, including well-established healthcare infrastructure, technological advancements, a robust regulatory framework, and high healthcare expenditure. Additionally, the presence of key market players and continuous research and development activities contribute to North America’s strong market position. Increasing awareness among patients, favourable reimbursement policies, and a growing geriatric population further drive the market growth in the region. These factors collectively contribute to North America’s continued dominance and projected growth in the forecast period.
Region – Embolic Protection Devices Market breakup from 5 Regions:
- North America
- Latin America
- Middle-East & Africa
Key Companies Analysis
In the highly competitive global market, key players in the Embolic Protection Devices industry have implemented various market strategies, including mergers and acquisitions, to maintain their industry share and expand their product portfolio. Notable companies in the EPDs market include Medtronic, Abbott Laboratories, Boston Scientific, Cordis, Silk Road Medical, Abiomed, and Edwards Lifesciences Corporation. These companies are actively involved in driving innovation, developing advanced technologies, and meeting the evolving demands of healthcare professionals and patients in the field of embolic protection. Their strategic initiatives contribute to the growth and development of the Embolic Prevention Devices Market on a global scale.
All key players have been covered from 3 viewpoints:
- Recent Development
- Financial Insight
- Abbott Laboratories
- Boston Scientific
- Silk Road Medical
- Edwards Lifesciences Corporation.
About the Company:
Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: [email protected]